14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.90 $3.93 Friday, 3rd May 2024 RVPH stock ended at $3.20. This is 0.629% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.79% from a day low at $3.11 to a day high of $3.29.
90 days $2.67 $4.82
52 weeks $2.67 $9.18

Historical Reviva Pharmaceuticals Holdings, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $3.29 $3.29 $3.11 $3.20 109 244
May 02, 2024 $3.29 $3.30 $3.14 $3.18 87 090
May 01, 2024 $3.09 $3.29 $3.09 $3.26 78 760
Apr 30, 2024 $2.91 $3.15 $2.90 $3.06 112 878
Apr 29, 2024 $2.98 $3.07 $2.90 $2.90 112 343
Apr 26, 2024 $2.97 $3.08 $2.94 $2.99 115 227
Apr 25, 2024 $3.01 $3.10 $2.90 $2.98 107 136
Apr 24, 2024 $3.01 $3.13 $2.90 $3.02 77 687
Apr 23, 2024 $3.15 $3.19 $3.01 $3.06 77 792
Apr 22, 2024 $3.05 $3.15 $2.95 $3.09 111 535
Apr 19, 2024 $3.00 $3.08 $2.95 $3.02 139 324
Apr 18, 2024 $3.20 $3.20 $2.98 $3.02 123 704
Apr 17, 2024 $3.30 $3.35 $3.17 $3.20 98 295
Apr 16, 2024 $3.34 $3.42 $3.27 $3.33 93 097
Apr 15, 2024 $3.43 $3.60 $3.00 $3.48 733 778
Apr 12, 2024 $3.72 $3.81 $3.66 $3.69 91 274
Apr 11, 2024 $3.69 $3.80 $3.62 $3.79 178 276
Apr 10, 2024 $3.56 $3.68 $3.51 $3.68 65 658
Apr 09, 2024 $3.63 $3.67 $3.49 $3.64 127 711
Apr 08, 2024 $3.56 $3.64 $3.44 $3.63 86 005
Apr 05, 2024 $3.60 $3.61 $3.43 $3.58 142 444
Apr 04, 2024 $3.65 $3.93 $3.52 $3.62 442 439
Apr 03, 2024 $3.43 $3.70 $3.36 $3.66 196 570
Apr 02, 2024 $3.28 $3.48 $3.26 $3.47 213 284
Apr 01, 2024 $3.74 $3.74 $3.25 $3.38 424 446
Click to get the best stock tips daily for free!

About Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings. Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase... RVPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT